Medicine
RELIVZATE
Key ingredient(s)
Lamivudine; Tenofovir Disoproxil Fumarate
Available forms & strengths
Request this medicine| Form | Strength | Pack | Route | Icon |
|---|---|---|---|---|
| TABLET | 300,0 mg; 245,0 mg | — | Oral |
|
Notes: SAHPRA secureId: CfDJ8L67LitnFgdOq0Uv0zyh2bqAwpXk4_mKPEkeNIQVgR2xh-jwTRsoZ7VtHUuwgrpC3hKtH5PUNYy-S_deCLLnjUS2aEVGpA9xtpwcOk1m_FlrXmzF7Krme9OD4sK0XzYCrA | Reg: 57/20.2.8/0166 | AppNo: 570166 | RegDate: 2023/02/28 | Applicant: Austell Pharmaceuticals (Pty) Ltd | Status: Registered